Intranasal delivery comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-01-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
Proposed mechanisms centre on the GABAergic system. Animal and tissue studies report changes in GABA-A receptor expression and reduced activity of GABA transaminase, the enzyme that degrades GABA. Effects on monoamine turnover, including serotonin and dopamine pathways, are also described, and a separate line of work links the peptide to increased expression of brain-derived neurotrophic factor in hippocampal tissue. Most of these findings come from rodent models and cell preparations. How the individual observations combine into a single coherent mode of action is not settled.
Pharmacokinetic data are sparse and largely derived from animal work. After intranasal administration the peptide appears in plasma within minutes, and reported half-lives are short, on the order of minutes to tens of minutes. Degradation proceeds through ordinary proteolytic cleavage into constituent amino acids and smaller fragments. Direct evidence that intact Selank reaches brain tissue in meaningful amounts is limited, and the extent of blood-brain barrier penetration is debated. Some authors argue that fragments, not the parent peptide, carry much of the observed activity.
Animal studies have examined behaviour in tests of anxiety, memory retention and stress response, and several report changes in neurotrophic or neurotransmitter-related markers. The human evidence base is much smaller, consisting mainly of short trials conducted in Russia with limited reporting in English-language journals. Sample sizes are modest and outcome measures vary between studies, so the findings are best described as preliminary. Independent replication under modern trial standards has not been widely reported.
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
| Property | Value | Notes |
|---|---|---|
| Primary route studied | Intranasal | Also examined parenterally in animal work |
| Reported plasma half-life | Minutes to tens of minutes | Values vary widely between reports |
| Main model systems | Rodent behavioural and cell assays | Human trials are few and small |
| Principal proposed targets | GABA-A receptor, GABA transaminase | Monoamine and neurotrophic pathways also reported |
| Evidence grade | Preliminary | Limited independent replication |
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, with mass spectrometry used to confirm molecular mass and sequence information. Amino acid analysis and peptide mapping may supplement these methods. Certified reference standards are scarce, and many commercial lots are sold as research chemicals without a pharmacopoeial monograph. Regulatory treatment differs by country: Selank is a registered prescription medicine in Russia, while in the European Union and the United States it is not an approved drug and may fall under research-chemical or unapproved-product frameworks.
Selank is a hydrophilic peptide and dissolves readily in water and in aqueous buffers. The lyophilised powder is typically a white to off-white solid. Because short peptides are prone to hydrolysis and oxidation, handling benefits from limiting exposure to heat, moisture and strong light. Working solutions are commonly prepared in sterile water or saline, and repeated freeze-thaw cycles are avoided to reduce aggregation and loss of activity. These practices reflect general laboratory convention rather than published stability specifications.
The Chanka people lived in the Huancavelica, Ayacucho, and Apurímac regions of Peru. The Huanca people of the Junín Region of Peru spoke Quechua before the Incas did. The Inca established the largest empire of the pre-Columbian era. The Chincha, an extinct merchant kingdom of the Chincha Islands of Peru. The Qolla inhabited the Potosí, Oruro, and La Paz departments of Bolivia. The Cañari of Ecuador adopted the Quechua language from the Inca. The speakers of Quechua total some 5.1 million people in Peru, 1.8 million in Bolivia, 2.5 million in Ecuador (Hornberger and King, 2001), and according to Ethnologue (2006) 33,800 in Chile, 55,500 in Argentina, and a few hundred in Brazil. Only a slight sense of common identity exists among these speakers spread all over Peru, Bolivia and Ecuador. The various Quechua dialects are in some cases so different from one another that mutual understanding is not possible. Quechua was spoken not only by the Incas, but also by long-term enemies of the Inca Empire, including the Huanca (Wanka is a Quechua dialect spoken today in the Huancayo area) and the Chanka (the Chanca dialect of Ayacucho) of Peru, and the Kañari (Cañari) in Ecuador. Quechua was spoken by some of these people, for example, the Wanka, before the Incas of Cusco, while other people, especially in Bolivia but also in Ecuador, adopted Quechua only in Inca times or afterward. Some Christian organizations also refer to a "Quechua people", such as the Christian shortwave radio station HCJB, "The Voice of the Andes" (La Voz de los Andes).
=== Humans === The FPR3 gene was cloned and named based on the similarity of the amino acid sequence which it encodes to that encoded by the gene for FPR1 (see formyl peptide receptor 1 for details) The studies indicated that FPR3 is composed of 352 amino acids and its gene, similar to FPR1, has an intronless open reading frames which encodes a protein with the 7 transmembrane structure of G protein coupled receptors; FPR3 has 69% and 72% amino acid sequence identities with FPR1. All three genes localize to chromosome 19q.13.3 in the order of FPR1 (19q13.410), FPR2 (19q13.3-q13.4), and FPR3 (19q13.3-q13.4) to form a cluster which also includes the genes for another G protein-coupled chemotactic factor receptor, the C5a receptor (also termed CD88) and GPR77, and a second C5a receptor, C5a2 (C5L2), which has the structure of a G protein coupled receptor but fails to couple to G proteins and is of debated function.
Medical terminology is language used to describe the components, processes, conditions, medical procedures and treatments of the human body. In the English language, medical terminology generally has a regular morphology; the same prefixes and suffixes are used to add meanings to different roots. The root of a term often refers to an organ, tissue, or condition, and medical roots and affixes are often derived from Ancient Greek or Latin (particularly Neo-Latin). Many medical terms are examples of neoclassical compounds. Historically, all European universities used Latin as the dominant language of instruction and research, as Neo-Latin was the lingua franca of science, medicine, and education in Europe during the early modern period. Medical terminology includes a large part of anatomical terminology, which includes the anatomical terms of location, motion, muscle, bone, and histology. It also includes language from biology, chemistry, physics, and physiology, as well as vocabulary unique to the field of medicine, such as medical abbreviations. Each branch of medicine has its own clinical and scientific terminology. Medical dictionaries are specialised dictionaries for medical terminology and may be organised alphabetically or according to medical classification systems such as the Systematized Nomenclature of Medicine, International Classification of Diseases, or Unified Medical Language System. Examples of modern medical dictionaries include Mosby's Dictionary of Medicine, Nursing & Health Professions, Stedman's, Taber's, and Dorland's.
=== Electrocardiogram === Electrocardiography (ECG/EKG in German vernacular. Elektrokardiogram) monitors electrical activity of the heart, primarily as recorded from the skin surface. A 12 lead recording, recording the electrical activity in three planes, anterior, posterior, and lateral is the most commonly used form. The ECG allows observation of the heart electrical activity by visualizing waveform beat origin (typically from the sinoatrial or SA node) following down the bundle of HIS and ultimately stimulating the ventricles to contract forcing blood through the body. Much can be learned by observing the QRS morphology (named for the respective portions of the polarization/repolarization waveform of the wave, P,Q,R,S,T wave). Rhythm abnormalities can also be visualized as in slow heart rate bradycardia, or fast heart rate tachycardia.
Sources: en.wikipedia.org
One of the first common applications of surface plasmon resonance spectroscopy was the measurement of the thickness (and refractive index) of adsorbed self-assembled nanofilms on gold substrates. The resonance curves shift to higher angles as the thickness of the adsorbed film increases. This example is a 'static SPR' measurement. When higher speed observation is desired, one can select an angle right below the resonance point (the angle of minimum reflectance), and measure the reflectivity changes at that point. This is the so-called 'dynamic SPR' measurement. The interpretation of the data assumes that the structure of the film does not change significantly during the measurement.
In April 2024, a World Health Organization spokeswoman stated, "Different doctors particularly in the maternity hospitals are reporting that they’re seeing a big rise in children born [with] low birth weight and just not surviving the neonatal period because they are born too small".
The above examples envisage nuclear warfare at a strategic level, i.e., total war. However, nuclear powers have the ability to undertake more limited engagements. "Sub-strategic use" includes the use of either "low-yield" tactical nuclear weapons, or of variable yield strategic nuclear weapons in a very limited role, as compared to exchanges of larger-yield strategic nuclear weapons over major population centers. This was described by the UK Parliamentary Defence Select Committee as "the launch of one or a limited number of missiles against an adversary as a means of conveying a political message, warning or demonstration of resolve". It is believed that all current nuclear weapons states possess tactical nuclear weapons, with the exception of the United Kingdom, which decommissioned its tactical warheads in 1998. However, the UK does possess scalable-yield strategic warheads, and this technology tends to blur the difference between "strategic", "sub-strategic", and "tactical" use or weapons. American, French and British nuclear submarines are believed to carry at least some missiles with dial-a-yield warheads for this purpose, potentially allowing a strike as low as one kiloton (or less) against a single target. Only the People's Republic of China and the Republic of India have declarative, unqualified, unconditional "no first use" nuclear weapons policies. India and Pakistan maintain only a credible minimum deterrence.
Other prominent Han Chinese who have made notable contributions the development and growth of modern science and technology include the medical researcher, physician, and virologist David Ho, who was one of the first scientists to propose that AIDS was caused by a virus, thus subsequently developing combination antiretroviral therapy to combat it. In recognition of his medical contributions, Ho was named Time magazine Person of the Year in 1996. The medical researcher and transplant surgeon Patrick Soon-Shiong is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is also well known for performing the first whole-pancreas transplant and he developed and first performed the experimental Type 1 diabetes-treatment known as encapsulated-human-islet transplant, and the "first pig-to-man islet-cell transplant in diabetic patients." The physician and physiologist Thomas Ming Swi Chang is the inventor of the world's first artificial cell made from a permeable plastic sack that would effectively carry hemoglobin around the human circulatory system. Chang is also noteworthy for his development of charcoal-filled cells to treat drug poisoning in addition to the discovery of enzymes carried by artificial cells as a medical tool to correct the faults within some metabolic disorders.
Initiation reactions are those that result in a net increase in the number of radicals. They may involve the formation of radicals from stable species as in Reaction 1 above or they may involve reactions of radicals with stable species to form more radicals. Propagation reactions are those reactions involving radicals in which the total number of radicals remains the same. Termination reactions are those reactions resulting in a net decrease in the number of radicals. Typically two radicals combine to form a more stable species, for example:
Sources: en.wikipedia.org
Reports describe modulation of GABA signalling, changes in monoamine turnover and effects on neurotrophic factor expression. These observations come mainly from animal and cell studies. A single unifying mechanism has not been demonstrated.
The peptide enters plasma rapidly and is broken down by ordinary proteases into amino acids and shorter fragments. Reported half-lives are short. Whether meaningful amounts of the intact molecule reach the brain is an open question.
Most clinical reports are small, published in Russian and not independently replicated. English-language reviews highlight the absence of large randomised trials. Conclusions about efficacy should be treated as provisional.
Most published work uses intranasal application, either as drops or as a nasal spray. Injection routes appear in a smaller set of animal experiments. Oral use is uncommon in the literature because peptide breakdown and poor absorption limit this route.